65 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
29 Jul 24
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
9:04pm
on all matters, for each Class A Multiple Voting Share held.
Each nominee listed in the Company's management information circular dated June 10, 2024 … in the Circular (the "Class A Multiple Voting Share Issuance").
Resolution
Votes For:
Votes Withheld:
Votes Against:
Number
Percentage
Number
6-K
EX-99.3
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
all of the important information contained in the information circular and other proxy materials before voting.
The information circular and other … to be voted on at the meeting are listed below along with the Sections within the Information Circular where disclosure regarding the matter can be found
6-K
EX-99.4
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
the remuneration of the auditor, as more particularly set forth in the Circular.
Share Consolidation
For
Against
To consider and, if deemed advisable … ” under the Company’s articles, as further described in the Circular.
Issuance of Additional MVS
For
Against
The holders of Class B Subordinate Voting
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
INFORMATION CIRCULAR
DATED: JUNE 10, 2024
FSD PHARMA INC.
199 Bay St., Suite 4000
Toronto, Ontario M5L 1A9
NOTICE OF ANNUAL GENERAL AND SPECIAL
MEETING … ”) for the ensuing year, as more particularly set forth in the accompanying management information circular dated July 10, 2024, and prepared for the purpose
6-K
EX-99.5
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
forth in the Circular.
Share Consolidation
For
Against
To consider and, if deemed advisable, to pass with or without variation, a special resolution … in the Circular.
Issuance of Additional MVS
For
Against
The holders of Class B Subordinate Voting Shares, exclusive of Class B Subordinate Voting Shares held
6-K
09sqhqrdchgrqkn tf8m
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
6-K
EX-99.2
789z3ka1af
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
424B5
x6zo cq4hfijwm
16 Feb 24
Prospectus supplement for primary offering
6:36pm
F-3
zez7qz7
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.1
r5vgxyj8axyl fo3
30 Nov 23
FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
8:37am
6-K
EX-99.1
yaasavk9neqmc3fa65z
27 Nov 23
FSD Pharma Inc. Obtains Final Order for Plan of Arrangement
7:48am
6-K
xr8x8
21 Nov 23
Current report (foreign)
10:32am
6-K
EX-99.1
5ua6684
21 Nov 23
Current report (foreign)
10:32am
6-K
EX-99.1
b27ysjbnwun1twfde3as
17 Nov 23
FSD Pharma Announces Distribution Date for Distribution of
8:01am
6-K
EX-99.1
bq3m dnpbmpdeuy03
15 Nov 23
Current report (foreign)
9:13am
6-K
7wyiwl71m4jhkj0d3 az
15 Nov 23
Current report (foreign)
9:13am
6-K
EX-99.2
isk6 mg5itps2u730
7 Nov 23
Material Change Report
10:34am